
Drug used to reduce blood fats may cut SARS-CoV-2 infection by 70 per cent: Study
India Today
The team led by researchers from the University of Birmingham in the UK found that an oral drug used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent.
An oral drug used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, according to a lab study published on August 6. The team led by researchers from the University of Birmingham in the UK found that fenofibrate and its active form fenofibric acid can significantly reduce SARS-COV-2 infection, which causes Covid-19, in human cells in the laboratory.More Related News

Egypt has emerged as a key back-channel mediator, establishing contact with Iran's IRGC and proposing a five-day pause in fighting to build momentum for a ceasefire, a move that appears to have nudged US President Donald Trump to drop his threat to strike Iran's power plants, The Wall Street Journal reported.












